Abstract
Severe cortex lesions in the hippocampal, parahippocampal and medial temporal lobe (MTL) of Alzheimers disease subjects have been observed by functional magnetic resonance imaging (fMRI) during memory task performance. To date, fMRI technology has not been used to investigate the frontal lobe function of Alzheimers subjects. This study determines if fMRI can be used to assess altered prefrontal cortex activity during Stroop task performance in subjects wih mild cognitive impairment (MCI) and Alzheimers disease (AD). Functional magnetic resonance imaging (fMRI) was performed on 9 healthy elderly controls, 9 subjects with mild cognitive impairment and 10 patients with Alzheimers disease, to examine the prefrontal changes in fMRI activation in relation to the Stroop color-word paradigm. In comparison with controls, MCI subjects showed distinctly increased cortex activity including: the dorsal anterior cingulate, bilateral middle and inferior frontal gyri, bilateral inferior parietal lobule, and the bilateral insular. In contrast, AD subjects exhibited decreased fMRI responses in the regions of the prefrontal cortex listed above. These results imply two different neurophysiological characteristics of MCI and AD. In MCI, a compensatory activity of the prefrontal cortex is observed, whereas in AD a dysfunction of the prefrontal cortex is indicated.
Keywords: Alzheimer's disease, Mild cognitive impairment, Stroop task, fMri
Current Alzheimer Research
Title: An fMRI Stroop Task Study of Prefrontal Cortical Function in Normal Aging, Mild Cognitive Impairment, and Alzheimers Disease
Volume: 6 Issue: 6
Author(s): Chuanming Li, Jian Zheng, Jian Wang, Li Gui and Chuan Li
Affiliation:
Keywords: Alzheimer's disease, Mild cognitive impairment, Stroop task, fMri
Abstract: Severe cortex lesions in the hippocampal, parahippocampal and medial temporal lobe (MTL) of Alzheimers disease subjects have been observed by functional magnetic resonance imaging (fMRI) during memory task performance. To date, fMRI technology has not been used to investigate the frontal lobe function of Alzheimers subjects. This study determines if fMRI can be used to assess altered prefrontal cortex activity during Stroop task performance in subjects wih mild cognitive impairment (MCI) and Alzheimers disease (AD). Functional magnetic resonance imaging (fMRI) was performed on 9 healthy elderly controls, 9 subjects with mild cognitive impairment and 10 patients with Alzheimers disease, to examine the prefrontal changes in fMRI activation in relation to the Stroop color-word paradigm. In comparison with controls, MCI subjects showed distinctly increased cortex activity including: the dorsal anterior cingulate, bilateral middle and inferior frontal gyri, bilateral inferior parietal lobule, and the bilateral insular. In contrast, AD subjects exhibited decreased fMRI responses in the regions of the prefrontal cortex listed above. These results imply two different neurophysiological characteristics of MCI and AD. In MCI, a compensatory activity of the prefrontal cortex is observed, whereas in AD a dysfunction of the prefrontal cortex is indicated.
Export Options
About this article
Cite this article as:
Li Chuanming, Zheng Jian, Wang Jian, Gui Li and Li Chuan, An fMRI Stroop Task Study of Prefrontal Cortical Function in Normal Aging, Mild Cognitive Impairment, and Alzheimers Disease, Current Alzheimer Research 2009; 6 (6) . https://dx.doi.org/10.2174/156720509790147142
DOI https://dx.doi.org/10.2174/156720509790147142 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Patents and Emerging Therapeutics in the Treatment of Allergic Conjunctivitis
Recent Patents on Inflammation & Allergy Drug Discovery The Neurotachykinin NK1 Receptor – A Novel Target for Diagnostics and Therapy
Current Molecular Imaging (Discontinued) Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design Neuroprotective Efficacy of the Peroxisome Proliferator-Activated Receptor-γ Ligand in Chronic Cerebral Hypoperfusion
Current Neurovascular Research The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy
Current Stem Cell Research & Therapy AMPA Receptor Antagonists with Additional Mechanisms of Action: New Opportunities for Neuroprotective Drugs?
Current Pharmaceutical Design Radioprotective Gene Therapy
Current Gene Therapy Seasonal and Perennial Allergic Conjunctivitis
Recent Patents on Inflammation & Allergy Drug Discovery Salen Mn Complexes are Superoxide Dismutase/Catalase Mimetics that Protect the Mitochondria
Current Inorganic Chemistry (Discontinued) Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research Interferons: Mechanisms, Biological Activities and Survey of their Use in Human Diseases
Current Bioactive Compounds Environment, Physical Activity, and Neurogenesis: Implications for Prevention and Treatment of Alzhemiers Disease
Current Alzheimer Research Therapeutic Effects of Renal Denervation on Renal Failure
Current Neurovascular Research The Immunosuppressive Agent FK506 Prevents Subperineurial Degeneration and Demyelination on Ultrastructural and Functional Analysis
Current Neurovascular Research Radiolabeled Imaging Probes Targeting Angiogenesis for Personalized Medicine
Current Pharmaceutical Design NO Chimeras as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Neuroprotective Effects of Drug-Induced Therapeutic Hypothermia in Central Nervous System Diseases
Current Drug Targets The Effects of P75NTR on Learning Memory Mediated by Hippocampal Apoptosis and Synaptic Plasticity
Current Pharmaceutical Design Directed Differentiation of Pluripotent Cells Towards Therapeutic Stem Cells
Recent Patents on Regenerative Medicine Circulating Biomarkers for the Diagnosis and Prognosis of Heart Failure
Current Medicinal Chemistry